Foundation Fighting Blindness Retinal Degeneration Fund - 30 Apr 2025 SCHEDULE 13D/A Report for Opus Genetics, Inc. Common Stock, $0.0001 par value per share (IRD)

Filing Manager
Foundation Fighting Blindness Retinal Degeneration Fund
Reporting Manager
Foundation Fighting Blindness Retinal Degeneration Fund
Security
Opus Genetics, Inc. Common Stock, $0.0001 par value per share
Symbol
IRD
Shares outstanding
59,699,189 shares
Disclosed Ownership
9,492,171 shares
Ownership
16%
Form type
SCHEDULE 13D/A
Filing time
06 May 2025, 17:55:07 UTC
Date of event
30 Apr 2025
Next filing
11 Dec 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Foundation Fighting Blindness Retinal Degeneration Fund 16% 9,492,171 0 9,492,171 /s/ Russell Kelley Russell Kelley, Managing Director 0002042266
Foundation Fight Blindness, Inc. 16% 9,492,171 0 9,492,171 /s/ Jason Menzo Jason Menzo, Chief Executive Officer